AbbVie, Inc. (ABBV)
265.12
+0.04
(+0.02%)
USD |
NYSE |
Sep 24, 16:00
264.66
-0.46
(-0.17%)
Pre-Market: 05:14
AbbVie Gross Profit (Annual) : 42.89B for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 42.89B |
| December 31, 2024 | 39.50B |
| December 31, 2023 | 37.67B |
| December 31, 2022 | 41.61B |
| December 31, 2021 | 39.05B |
| December 31, 2020 | 31.69B |
| December 31, 2019 | 25.66B |
| December 31, 2018 | 25.20B |
| December 31, 2017 | 21.41B |
| Date | Value |
|---|---|
| December 31, 2016 | 19.82B |
| December 31, 2015 | 18.16B |
| December 31, 2014 | 15.65B |
| December 31, 2013 | 14.24B |
| December 31, 2012 | 13.85B |
| December 31, 2011 | 12.83B |
| December 31, 2010 | 11.31B |
| December 31, 2009 | 10.17B |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Biogen, Inc. | 6.454B |
| Gilead Sciences, Inc. | 23.22B |
| Regeneron Pharmaceuticals, Inc. | 11.70B |
| Amgen, Inc. | 26.01B |
| REGENXBIO, Inc. | 134.53M |